CANCER-IMMUNOTHERAPY USING INTERLEUKIN-2 AND INTERLEUKIN-2-ACTIVATED LYMPHOCYTES

被引：273

作者：

ROSENBERG, SA

LOTZE, MT

机构：

来源：

ANNUAL REVIEW OF IMMUNOLOGY | 1986年 / 4卷

关键词：

D O I：

10.1146/annurev.iy.04.040186.003341

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

收藏

页码：681 / 709

页数：29

相关论文

共 75 条

[1]

BAKER PE, 1978, J IMMUNOL, V121, P2168

[2] CLEARANCE RATES AND SYSTEMIC EFFECTS OF INTRAVENOUSLY ADMINISTERED INTERLEUKIN-2 (IL-2) CONTAINING PREPARATIONS IN HUMAN-SUBJECTS [J].

BINDON, C ;

CZERNIECKI, M ;

RUELL, P ;

EDWARDS, A ;

MCCARTHY, WH ;

HARRIS, R ;

HERSEY, P .

BRITISH JOURNAL OF CANCER, 1983, 47 (01) :123-133

[3]

CHANG AE, 1984, J BIOL RESP MODIF, V3, P561

[4] AUGMENTATION OF THE ANTI-TUMOR THERAPEUTIC EFFICACY OF LONG-TERM CULTURED LYMPHOCYTES-T BY INVIVO ADMINISTRATION OF PURIFIED INTERLEUKIN-2 [J].

CHEEVER, MA ;

GREENBERG, PD ;

FEFER, A ;

GILLIS, S .

JOURNAL OF EXPERIMENTAL MEDICINE, 1982, 155 (04) :968-980

[5]

CHEEVER MA, 1977, J IMMUNOL, V119, P714

[6]

CHEEVER MA, 1984, J IMMUNOL, V132, P2259

[7]

CLASON AE, 1982, J IMMUNOL, V129, P252

[8]

DONOHUE JH, 1984, J IMMUNOL, V132, P2123

[9]

DONOHUE JH, 1984, CANCER RES, V44, P1380

[10]

EBERLEIN TJ, 1982, J EXP MED, V156, P385

← 1 2 3 4 5 6 7 8 →